A study to collect information about the causes and treatment of melanoma skin cancer (MyMelanoma)
Cancer type:
Status:
Phase:
This study is to collect information about melanoma causes and treatment. It is open to people who have had or have melanoma. Some family members can also take part.
More about this trial
The MyMelanoma team are building a database to help support future research into melanoma skin cancer. The database will include information about the:
- causes of melanoma
- treatment of melanoma
They will do this by:
- asking people to fill in questionnaires
- collecting information about people with melanoma from their medical records
- collecting samples such as spit (saliva), blood and poo. You do not need to agree to provide samples in order to take part.
All the information that goes on to the database is anonymous. You cannot be identified by the information you provide or that the team collect.
The database is open to researchers around the world. The aim is that researchers can use the information to answer key questions about melanoma more quickly.
Please note you will not gain any benefit from joining the study. The information you provide could help people in the future who have melanoma.
Who can enter
The following is a summary of the entry conditions for this study. Talk to your doctor or the study team if you are unsure about any of these. They will be able to advise you.
Who can take part
People with melanoma
You may be able to join this study if you are at least 16 years old and have had treatment in the NHS for:
Family members of people with melanoma
You may be able to join if a member of your family is taking part in the study and they have asked you to join. This is because there is evidence that melanoma occurs more often than average in your family. It is a 
.
Who can’t take part
You cannot join this study if you do not have access to email, a computer or a smartphone.
Trial design
The team need 20,000 people to join the study. You do not need to make any additional visits to hospital when taking part in the study. You complete all the study documents and collect the samples at home.
How to join and what you need to do
Your melanoma healthcare team might tell you about the study and give you a leaflet about it. On the leaflet is a website link for the MyMelanoma study. The website gives you more information about the study. This includes:
- written information explaining the study
- video clips that explain the study
You can ask questions about the study by email or if you prefer a member of the study team can phone you.
When you agree to take part in the study you give your on the website.
After agreeing to take part you fill in a form giving your:
- full name
- date of birth
- home address and email address. You can give your telephone number as well if you prefer to talk to someone at the beginning.
- NHS number. You can give this later if you don’t have it at the time.
As part of the study you:
- fill in 2 questionnaires within 2 weeks of joining. One questionnaire asks about melanoma and your family history. The other asks about lifestyle and health.
- give permission for the study team to look at your medical notes
- give permission for the team to ask for a small piece of tissue from a previous tissue sample (
biopsy ) of your melanoma - agree to have any results from the biopsies put on the MyMelanoma database
The team will contact you once a year by email. This is to see if there has been any change to your health. You can ask the team to stop contacting you with the yearly emails if you want to.
The team might also ask if you are willing to take part in another study. You don’t have to agree to take part in another study if you don’t want to.
All the information you give on the website is safe, secure and . No one is able to identify you.
Any samples you give as part of the study are stored in a safe and secure manner. The samples will not have your name or any other personal details attached to them that might identify you.
Hospital visits
There are no hospital visits if you take part in this study.
Side effects
There are no side effects to taking part in this study.
Location
Recruitment start:
Recruitment end:
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Chief Investigator
Professor Mark Middleton
Supported by
Cancer Research UK
Melanoma Focus
University of Oxford
University of Highlands and Islands
Other information
For more information you can look at www.mymelanomastudy.org website.
If you have questions about the trial please contact our cancer information nurses
Freephone 0808 800 4040
